Hang Lung Group Limited (HNLGF)

1.27

0.00 (0.00%)

At close: Apr 25, 2025, 8:00 PM

Hang Lung Income Statement

Financials in HKD. Fiscal year is January - December.

Fiscal Year	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019	Q4 2018	Q2 2018	Q4 2017	Q2 2017	Q4 2016	Q2 2016
Period Ending	Jun 30, 2024	Dec 31, 2023	Jun 30, 2023	Dec 31, 2022	Jun 30, 2022	Dec 31, 2021	Jun 30, 2021	Dec 31, 2020	Jun 30, 2020	Dec 31, 2019	Jun 30, 2019	Dec 31, 2018	Jun 30, 2018	Dec 31, 2017	Jun 30, 2017	Dec 31, 2016	Jun 30, 2016
Revenue	11.87B	10.88B	10.85B	10.94B	11.26B	10.93B	10.37B	9.56B	9.4B	9.57B	9.35B	10.45B	11.01B	11.99B	13.78B	13.78B	11.47B
Cost of Revenue	4.36B	3.09B	3.07B	3.26B	3.36B	3.11B	2.85B	2.65B	2.68B	1.46B	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	7.5B	7.79B	7.78B	7.68B	7.9B	7.82B	7.52B	6.91B	6.72B	8.1B	9.35B	10.45B	11.01B	11.99B	13.78B	13.78B	11.47B
Operating Income	5.99B	7.11B	7.09B	7B	7.25B	7.2B	6.98B	6.35B	6.04B	6.33B	6.36B	6.97B	7.23B	7.87B	8.83B	8.8B	7.45B
Interest Income	92M	102M	88M	73M	69M	82M	83M	70M	91M	133M	428M	646M	643M	610M	468M	269M	72M
Pretax Income	5.04B	6.45B	6.71B	6.2B	6.44B	7.28B	5.27B	-633M	-1.9B	6.17B	10.71B	10.66B	11.82B	10.79B	9.43B	8.38B	7.19B
Net Income	2.02B	2.81B	2.96B	2.72B	2.52B	2.59B	1.56B	-1.54B	-233.38M	5.07B	5.96B	5.29B	5.96B	5.31B	4.32B	3.71B	3.22B
Selling & General & Admin	687M	680M	692M	673M	652M	618M	538M	559M	335M	362M	712M	707M	659M	656M	651M	671M	707M
Research & Development	52M	102M	88M	38M	n/a	n/a	n/a	n/a	56M	56M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	3.59B	1.18	1.23	-320M	-652M	-618M	-538M	-559M	-307M	2.38	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	6.23B	3.92B	3.65B	4.27B	4.43B	3.29B	4.86B	10.08B	13.13B	8.27B	1.63B	856M	1.46B	2.14B	3.88B	5.13B	4.23B
Interest Expense	1.09B	1.99B	1.69B	1.54B	1.48B	1.51B	1.54B	1.52B	1.51B	761M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	-299M	-592M	-617M	-324M	n/a	n/a	n/a	n/a	-261M	-261M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	5.88B	3.77B	3.77B	3.93B	4.01B	3.73B	3.39B	3.29B	4.82B	4.68B	1.63B	856M	1.46B	2.14B	3.88B	5.13B	4.23B
Income Tax Expense	1.57B	1.66B	1.62B	1.56B	1.87B	2.19B	1.94B	1.26B	433M	734M	1.31B	1.36B	1.45B	1.45B	1.55B	1.47B	1.21B
Shares Outstanding (Basic)	1.37B	1.36B	1.36B	1.36B	1.36B	1.36B	1.36B	1.36B	1.36B	1.36B	1.36B	1.36B	1.36B	1.36B	1.36B	1.36B	1.36B
Shares Outstanding (Diluted)	1.36B	1.36B	1.36B	1.36B	1.36B	1.36B	1.36B	1.36B	1.36B	1.36B	1.36B	1.36B	1.36B	1.36B	1.36B	1.36B	1.36B
EPS (Basic)	1.48	2.07	2.18	2.00	1.85	1.90	1.15	-1.13	-0.17	3.72	4.37	3.88	4.37	3.90	3.17	2.73	2.38
EPS (Diluted)	1.48	2.07	2.18	2.00	1.85	1.90	1.15	-1.13	-0.17	3.72	4.37	3.88	4.37	3.90	3.17	2.73	2.38
EBITDA	8.31B	14.26B	14.37B	13.74B	14.23B	14.97B	12.6B	5.92B	5.79B	5.88B	909M	-326M	177M	-1.11B	-2.96B	-1.65B	-1.06B
EBIT	11.67B	14.18B	14.3B	13.67B	14.16B	14.91B	12.55B	5.87B	15.97B	24.11B	18.77B	9.53B	9.32B	9.32B	8.95B	8.95B	6.08B
Depreciation & Amortization	-3.36B	88M	75M	78M	78M	62M	53M	48M	11.77B	8.52B	-6.36B	-6.97B	-7.23B	-7.87B	-8.83B	-8.8B	-7.45B